Sector revisions Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Equities
002603
CNE1000015S0
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.72 CNY | -0.45% |
|
+0.06% | +3.81% |
| 01-07 | Chinese Drug Regulator Accepts Yiling Pharmaceutical's Application for Qilong Dingchuan Tablets | MT |
| 01-07 | Yiling Pharmaceutical Unit Gets Nod to Market Dapagliflozin | MT |
Main competitors
| 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|
 | 3 | |||||||
| 6 | |||||||
| 9 | |||||||
| - | - | ||||||
| - | - | ||||||
| 4 | |||||||
| - | 1 | ||||||
| - | 1 | ||||||
| - | 1 | ||||||
| - | - | ||||||
| 2 | |||||||
| 11 | |||||||
| 2 | |||||||
| Average | 4 | |||||||
| Weighted average by Cap. | 5 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition